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Abstract

Introduction

The hypothesis that mild hyperoxa l uri a is
more important
than hyperca l ci uri a in the
pathogenesis of urolithiasis
is re-examined in
the light of new evidence.
Small increments in
urinary oxalate
in the normal to high-normal
range are much more critical
than similar rises
in urinary calcium for increasing the relative
supersaturation
of urine with respect to calcium
oxalate, the oxalate/calcium
ratio in urine, the
total
volume of calcium
oxalate
crystals
excreted,
the proportion
of abnormally large
crystals
and aggregates of calcium oxalate and
the severity of the disorder as defined by the
recurrence rate of stone-formation.
Data from
the Arabian Peninsula, where the prevalence of
calcium-containing
stones is considerably higher
than in the West, have shown that this occurs in
spite
of the almost
complete
absence
of
hyperca lei uri a.
On the other hand, there is a
strong association
between stone-formation
and
the occurrence of mild hyperoxaluria.
The lifetime expectancy of stone-formation
in men from
various countries
is strongly correlated
with
the average daily excretion of oxalate in the
urine of the normal men in these countries.
This relationship
extends to include patients
with enteric
and hereditary
hyperoxaluria.
There is no such relationship,
however, between
the life-time
expectancy of stones and urinary
calcium excretion in the same populations.
Studies
on the regulation
of urinary
oxalate indicate that it is largely controlled
by the quantity
of "free"
dietary
oxalate
available for absorption in the lower intestine
This can be calculated
from the intakes
of
calcium and oxalate and the urinary excretion of
calcium.

For over half a century, hypercalciuria
has
been considered by the majority of researchers
in the kidney stone field to be the main risk
factor for primary (idiopathic)
and secondary
calcium urol ithiasis
(Flocks, 1939; Albright et
al., 1953; Hodgkinson and Pyrah, 1958; Pak et
al.,
1975; Coe and Favus, 1980; Hal abe and
Sutton,
1987).
The main evidence cited
in
support of this hypothesis is that most we11control led studies
which have compared the
urinary excretions of minerals by stone-formers
and normals have shown that the patients tend to
excrete
more calcium
although
there
is
invariably a large degree of overlap between the
two groups.
This overlap is so considerable
that,
once allowance is made for the true
prevalence
of urinary stone-formation
in the
population,
the urinary calcium excretions
of
stone-formers all lie within the projected range
for the normal population,
albeit
within the
upper half of that range (Robertson et al.,
1978; Bataille
et al.,
1983; Robertson and
Peacock, 1985a).
There is certainly
not the
clear-cut separation between the urinary calcium
excretions
of calcium stone-formers
and their
controls
that
exists
between the
cystine
excretions of cystinuric stone-formers and their
controls (Robertson and Peacock, 1985b).
If the hypothesis that hypercalciuria
is
the main risk factor for calcium stone-formation
is correct,
then therapeutic
measures designed
to decrease urinary calcium excretion would be
expected to reduce the rate of recurrence of
calcium stone-formation
in patients
affected
with the disorder.
Although many of these
modalities,
such as thiazide diuretics
(Yendt,
1970; Coe and Kavalich,
1974),
cellulose
phosphate (Pak et al., 1974) and a low calcium
diet (Nordin et al., 1973), have been claimed to
have a benefi ci a 1 effect on stone recurrence,
more recent reports have cast doubt on their
efficacy.
Such doubts have arisen (a) because
of faults in the design of the studies concerned
( Churchi 11 , 1987), ( b) because the effect of a
particular
form of treatment
in long-term
studies seems to be minimal (Marickar and Rose,
1985), or (c) because the treatment concerned
leads to adverse changes in urine biochemistry,
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such as an increase in urinary oxalate or pH,
which may more than offset the beneficial effect
of reducing urinary calcium (Marshall and Barry,
1973; Hall son and Rose, 1978; Hall son, 1988).
There are growing doubts, therefore, about the
importance of hyperca lei uri a ~ as a major
risk factor for calcium stone-formation.
This
has led some of the former protagonists of the
"hypercalciuria theory" to turn their attention
to other possible urinary risk factors, such as
hypocitraturia (Pak et al., 1985) and defective
inhibitors
of
crystallization
such
as
"nephrocalcin" (Coe and Parks, 1990).
One important factor which these and many
other workers continue to overlook, however, is
the importance of mild hyperoxaluria in calcium
stone-formation.
Calcium oxalate, after all, is
consistently
the most common constituent
of
calcium-containing
calculi
in stone series
reported from all parts of the world and mild
hyperoxa1uri a should deserve at 1east as much
attention as hyperca1c i uri a as a factor in the
formation of such calculi.
The main problem for most potential
researchers in this area has been the difficulty
in measuring oxalate reliably
in biological
fluids.
Unlike the situation with respect to
the measurement of urinary calcium, the accurate
determination of oxalate in urine has only
become possible in recent years with the
application of the modern techniques of high
performance liquid chromatography (HPLC)(Hughes
et al., 1982), ion-chromatography (Menon and
Mahle, 1983; Robertson et al., 1982, Robertson
and Scurr,
1984) and gas chromatography
(Yanagawa et al., 1983). In general, however,
urinary oxalate (where measured at all) is still
assayed badly (Samuell, 1988), particularly when
using techniques other than those described
above. The reasons for the unre l i abi 1 ity of
most methods are multifactorial
but are most
frequently due to inadequate handling and workup of urine prior to the actua 1 measurement,
particularly in the case of urines which contain
crystals of calcium oxalate.
Unless great care
is taken either to acidify the entire urine
sample to at least pH 1.6 (Hodgkinson, 1981) or
to shake the whole urine thoroughly in order to
disperse the crystals homogeneously before subaliquot i ng, the probability of over- or underestimating oxalate is extremely high.
Even
collecting
the urine directly
into acid is
problematic since Stone Clinics are generally
unwilling to put sufficient acid (at least 100
ml of 1 molar HCl) in the container to ensure
that the overall pH will be less than 1.6 at the
end of the 24-hour collection.
In those laboratories which have taken all
the precautions necessary to ensure that the
urine is correctly handled before oxalate is
measured, important differences
between the
oxalate excretion of stone-formers and controls
have been reported (Robertson et al., 1971,
1978, 1989; Revusova et al., 1971; Baggio et
al., 1983; Bataille et al., 1983; Pena et al.,
1987; Larsson and Tisel ius, 1987; Rose, 1987;
Smith, 1991). However, there appears to be no
complete separation in oxalate excretion between

stone-formers and normals. In this respect mild
hyperoxal uri a does not appear to be different
from hypercalciuria.
More in-depth studies have
shown, however, that, when stone-formers are
studied when they first present with stones,
their mild hyperoxaluria is much more marked
than after they consult their urologist
or
physician (Robertson and Peacock, 1980). The
overlap between the oxalate excretions of stoneformers and normals when they first present is
much less than it is when they are referred
later to the specialist
Stone Clinic.
This
reduction following hospitalization
or outpatient consultation is now a recognised feature
of the so-called "stone clinic effect" (Hoskin
et al., 1983; Norman et al., 1984) and should
not be discounted in the assessment of patients
presenting with stones.
It would seem from the above evidence that
hypercalciuria and mild hyperoxaluria are both
commonfindings among stone-forming populations,
so why then has doubt been cast on the
importance of hypercalciuria in the pathogenesis
of stones and what new evidence is there to
support the hypothesis that mi1d hyperoxal uri a
is a much more significant
risk factor than
hypercalciuria for stone-formation?
Relative Importance of Hypercalciuria and Mild
Hyperoxaluria for Urolithiasis
The relative effects of hypercalciuria and
mild hyperoxaluria on the risk of calcium
oxalate stone-formation were first investigated
by Robertson and his co11eagues (Robertson and
Nordin, 1969; Robertson et al., 1971; Robertson
and Peacock, 1980). Their initial findings in
this respect have since been largely confirmed
by others (Bataille et al., 1983; Hallson, 1988;
Lindsjo, 1989).
The hypothesis that mild
hyperoxaluria
is much more critical
than
hypercalciuria in the pathogenesis of calcium
oxalate stone-formation was developed based on
findings obtained from both in vitro and in vivo
studies.
In Vitro Studies
Simple titration
studies on whole urine in
vitro indicated that it was extremely difficult
(and in most cases impossible) to produce
spontaneous crysta 11i zat ion of calcium oxalate
by the addition of a concentrated so 1ut ion of
calcium chloride, even up to total calcium
concentrations in urine of 15 to 20 mmol/1 well outside both the normal and stone-forming
ranges. On the other hand, it was found to be
possible to induce spontaneous crystallization
in almost every urine tested by the addition of
relatively
small quantities of a solution of
sodium oxalate (Robertson and Nordin, 1969).
Indeed, crysta"llization
was found to be
initiated spontaneously in most urines when the
oxalate
concentration
reached a value of
approximately 0.4 mmol/1 (the upper limit of
normal).
The chemical reason for this difference is
shown in the lower panels of Fig. 1 which
contain the bands of supersaturation
values

Oxalate in Urolithiasis
measured in urine in relation to increasing the
concentrations
of
calcium
and
oxalate
independently.
Clearly, the upper limit of
metastability
can be exceeded in only a few
cases by increasing urinary calcium alone
whereas it is exceeded in all urines whose
oxalate concentrations reach the upper limit of
normal.
The upper panels of Fig.
show the
relative
effects of independently increasing
urinary calcium and oxalate concentration on the
maximum volume of calcium oxalate crystals
produced. Whereas hypercalciuria has virtually
no influence on the volume of crystals produced,
mild hyperoxaluria produces a marked linear
increase in crystalluria.
Only in urines with a
very low calcium content is there a limited
relationship
between crystalluria
and calcium
concentration.
Another chemical factor (in addition to
supersaturation)
which
is
important
in
determining the volume and size of calcium
oxalate crystals and aggregates produced in a
given solution or urine is the ratio of
oxalate/calcium concentration.
Fig. 2 shows
that for any one of a number of defined initial
levels of supersaturation
with respect to
calcium oxalate, the closer the oxalate/calcium
ratio of the solution or urine is to 1: 1 the
greater is the volume of crystals produced.
These curves are extremely important in
explaining why stone-forming populations in the
Middle East have much more severe calcium

oxalate
crystalluria
than
stone-forming
populations in the West in spite of the fact
that both groups have approximately the same
initial
levels
of
calcium
oxalate
supersaturation
in their urine (Robertson et
al., 1989). The mean oxalate/calcium ratio in
the urine of recurrent stone-formers in Saudi
Arabia, for example, is 0.164 compared with
0.054 in the urine of recurrent stone-formers in
the UK. Both have approximately the same level
of supersaturation [between 1.10 and 1.20 on the
log (relative supersaturation) scale of Marshall
and Robertson (1976)] yet the Saudi stoneformers excrete about twice the volume of
crystals produced by their counterparts in the
UK. The reason why the Saudi stone-formers do
not have very much higher supersaturation values
than stone-formers in the UK is that their much
higher urinary oxalate excretions are largely
offset by their extremely low urinary excretions
of calcium (Robertson et al., 1989).
Fig. 2 clearly shows that an increase in
the oxalate/calcium ratio of urine is, in fact,
more important than an increase in the relative
supersaturation of urine with respect to calcium
oxalate in determining the volume of calcium
oxalate crystals produced. This factor has been
totally ignored by stone reseachers in the past
and has important implications for the treatment
of stone disease.
In addition to influencing the volume of
crystals produced in solution or in urine, an
increase in the oxalate/calcium ratio of the
medium to values closer to 1:1 markedly
increases the average size of the crystals and
aggregates generated (Fig. 3). This appears to
be a function of (a) the increase in the total
number of calcium oxalate crystals produced
which are available for agglomeration, (b) the
greater amount of "building material" available
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represent the formation and solubility products
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Fig. 4.
The volume concentration of calcium
oxalate crysta 1s in fresh warm urine samp1es
from a group of recurrent idiopathic calcium
stone-formers (a) on their basal diet, (b) on
their basal diet plus 25 mg/kg body weight of
additional calcium (given as calcium citrate)
and (c) on their basal diet plus 3 mg/kg body
weight of additional oxalate (given as sodium
oxalate).

to promote crystal growth and (c) the diminution
of the surface charge on the crystals which also
increases the degree of agglomeration.
This
last mentioned phenomenon is due to the fact
that, at low oxalate/calcium ratios in the
supernatant fluid, calcium oxalate crystals have
a net positive surface charge as a result of the
excess of calcium over oxalate ions in the
hydration
layer
surrounding
the
crystals
(Curreri et al., 1979; Scurr and Robertson,
1986). This net positive charge causes mutua1
repulsion between the crystals, thereby reducing
the probability of the crystals agglomerating.
When the
oxalate/calcium
ratio
of
the
supernatant approaches 1:1, however, the net
surface charge tends towards neutrality,
under
which conditions agglomeration becomes much more
likely.

the concentration of oxalate in urine: (a) the
total
volume of calcium oxalate crystals
excreted,
(b) the percentage by weight of
abnormally large crystals and aggregates of
ca 1c i um oxa1ate and (c) the recurrence rate of
stone-formation (Robertson and Peacock, 1980).
There were no re 1at i onshi ps, however, between
the same parameters and the concentration of
calcium in urine.
These findings
have
subsequent 1y been confirmed by Ha11son ( 1988)
and Lindsjo (1989).
The reason for the relatively
weak
relationship between the crystallization
markers
of stone disease and urinary calcium is
complicated (Robertson and Nordin, 1969).
Basically it is due to the combination of the
following factors:
(a) the formation of a
strong, soluble complex between Ca2+ and CO 2ions and (b) the relatively high calcium/oxaiate
ratio which prevails in most urines.
As a
consequence of this combination of factors, any
further increase in the urinary concentration of
ionized calcium ([Ca2+]) (which in normal urine
is about 20 times that of ionized oxalate
([C20/l)
is almost entirely
offset
by a
proportional decrease in the concentration of
ionized oxalate.
Thus the product of [Ca2+] x
[C2o/-l remains virtually constant over most of
the normo- to hypercalciuric
range.
This
contrasts
with the effect of independently
increasing the concentration of urinary oxalate
which, because oxalate is present in much lower
concentrations
than
calcium,
does
not
significantly reduce [Ca2+] by complexation when
it is increased.
The product of [Ca2+] x
[C2042-] therefore rises almost proportionally to
the increase in oxalate concentration in the
urine of most individuals in the population.

In Vivo Studies
In vivo studies (paralleling
the above
mentioned in vitro studies on the addition of
calcium to urine) were carried out in which an
oral load of calcium (in the form of calcium
cit rate sufficient to increase urinary ca lei um
by up to 60%) was given to stone-formers.
This
regimen failed to increase the volume of calcium
oxalate crystals
excreted by the patients
(Robertson et al.,
1969).
In contrast,
corresponding studies using an oral load of
sodium oxalate produced marked calcium oxalate
crystalluria in the same patients within about 2
to 3 hours (Fig. 4). Similar results have been
reported from studies in rats (Khan et al.,
1992). Together these in vivo findings bear out
the predictions which would be made from Figs.
1-3.
A further set of studies on calcium oxalate
crystalluria
in fresh urine samples maintained
at 37°C from recurrent, primary calcium stoneformers
showed that
there
are
strong
relationships between each of the following and
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DemographicStudies
Using the overlapping distributions
of
various parameters of stone-formation measured
in the urines of stone-formers and normal
subjects, Robertson and his colleagues (1978,
1981} constructed a "risk curve" for each
parameter which allowed a probability to be
calculated that a given individual is likely to
be a stone-former or not.
Comparison of the
various "risk curves" showed that the two most
important risk factors
for calcium stoneformation are a low urine volume (< 1 litre/day}
and mild hyperoxaluria
(> 0.45 mmol/day}.
Hypercalei uri a per se, on the other hand, was
the weakest of the six urinary risk factors
identified at that time as playing a significant
role in the pathogenesis of stones.
This
finding supports the conclusion drawn by
Marshall et al. (1975} from their studies on the
natural history of calcium stone disease that
there was no relationship between stone disease
and urinary calcium excretion.

appears to be a relatively weak risk factor for
the disorder.
Whenthe data from various countries on the
life-time
expectancy of stones in men are
compared with the average daily
urinary
excretions of calcium (Fig. 5} and oxalate (Fig.
6} in the normal male population of each of
these countries,
there is clearly a strong
positive relationship between stone disease and
urinary oxa1ate but not between stone disease
and urinary calcium excretion.
In fact, the
latter
relationship
appears to be generally
inverse except for those countries where urinary
oxalate does not increase as urinary calcium
decreases. A1so shown in Figs. 5 and 6 are the
90
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Studies in the Arabian Peninsula
Stone-formation is an extremely common
disorder in the affluent countries of the
Arabian Peninsula and Gulf area.
Current
estimates indicate that the life-time expectancy
of stones in men reaching the age of 60 is about
20%(Abdel-Halim et al., 1989; Robertson, 1993}.
This compares with a figure of 12 to 13% in
North America and Australasia (Sierakowski et
al., 1978; Johnson et al., 1979}, 9 to 10% in
Scandinavia (Ljunghall,
1978), 7 to 8% in
Western Europe (Vahlensieck et al.,
1982;
Robertson et al., 1983} and 5 to 6% in Japan
(Koide et al., 1986}. Interestingly, the figure
for Japan has been rising rapidly in the past
decade as urine composition has changed in the
population.
It has been suggested that these
changes are due to the increasing consumption of
animal protein in that country (lguchi et al.,
1990}.
Studies on the urine biochemistry of stoneformers and normal controls in the United Arab
Emirates (Husain et al., 1979; Al-Ali et al.,
1981} and in Saudi Arabia (Robertson et al.,
1989}, where the majority of stones contain
calcium oxalate (Barkworth et al., 1989}, have
shown that the very high prevalence rate of
stone-formation in that part of the world occurs
in
the
almost
complete
absence
of
hypercalciuria.
On the other hand, the urinary
excretion of oxalate is, on average, some 50 to
70%higher than in the corresponding populations
in the West.
This strongly supports the
hypothesis that mild hyperoxaluria is a much
more important risk factor than hypercal c i uri a
for the formation of calcium oxalate stones.
[It is interesting to note, in passing, that the
same arguments and type of data can be put
forward to show that the degree of alkalinity of
urine is a much more important risk factor for
calcium phosphate stone-formation
than is
hypercalciuria].
Thus, for both types of
calcium stone-formation, hypercalciuria ~
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mean prevalence figures for stone disease in
patients with enteric hyperoxaluria as a result
of bowel disease or following jejunoileal bypass
surgery (JIB) and in patients with primary
(hereditary) hyperoxaluria.
The data in Fig. 6
are
particularly
interesting
because the
relationship
betweeen the prevalence figures
from various countries and the average urinary
oxalate excretion in these countries appears to
continue linearly through the data collected
from the various well-recognised- hyperoxaluric
groups.
This suggests that the rel aHon ship
between the occurrence of stone disease and
urinary oxalate is a continuum over the entire
range of urinary oxalate excretion and that, if
urinary oxalate in the population is high
enough, then almost everyone will form stones.
The implications of the relationship
in
Fig. 6 are far-reaching.
Firstly, it implies
that urinary oxalate excretion is a major, if
not prime, determinant of stone prevalence in
the population.
Any factor which leads to an
increase in oxalate excretion
in a given
population, whether it be a high consumption of
oxalate, hyperabsorption of oxalate from the
diet, or increased endogenous production of
oxalate, will markedly increase the risk of
calcium oxalate-containing
stones
in that
population. Secondly, Fig. 6 implies that other
urinary risk factors, such as hyperca lei uri a,
hyperuricosuria
and hypocitraturia
must be
relatively unimportant as sole risk factors for
the disorder although they may still aggravate
the problem if they occur in conjunction with
mild hyperoxaluria.
Thirdly, it implies that
even if urinary inhibitors of crystallization,
such as
nephrocalcin,
glycosaminoglycans,
citrate,
pyrophosphate etc are important as
protective
agents
against
stones
under
conditions of normal oxaluria, they must be
capable of being overwhelmed when urinary
oxalate is increased above normal. Presumably,
this loss of activity is due to the marked
increase in calcium oxalate crystalluria
which
occurs as a result of mild hyperoxaluria (Fig.
1). As the volume of crystalluria
increases,
the crystal surface area which becomes available
to bind inhibitors may expand to levels which
deplete the amount of inhibitors present in the
urine concerned. Under these conditions crystal
growth and agglomeration may proceed at a
relatively uninhibited rate.

Causes of Hild Hyperoxaluria
There are three recognised causes of mild
hyperoxaluria
in the population:
(a) an
increased dietary intake of oxalate itself,
(b)
an increased intestinal
absorption of oxalate
from the diet, and (c) an increased endogenous
production
of oxalate
from ingested
or
metabolically-generated
precursors.
Other
suggested causes of mild hyperoxal uri a include
(d) a deficiency in oxalate utilisation
by
certain gut flora and (e) a decrease in the
tubular reabsorption (or increase in the tubular
secretion) of oxalate.

Increased dietary intake of oxalate
It is generally accepted that about 5-10%
of dietary oxalate is absorbed by the intestine
and is excreted in the urine.
This absorbed
dietary oxalate accounts for between 15 and 30%
of urinary oxalate. However, at greater intakes
of oxalate (> 2 mmol/day), absorbed oxalate
constitutes
an increasing percentage of the
urinary excretion and may reach values as high
as 50%. This percentage may be increased to 60%
when the high intake of oxa1ate is accompanied
by a low intake of calcium (Marshall et al.,
1972) or when vitamin D supplements are given to
increase calcium absorption (Erickson et al.,
1984).

Over a range of intakes of oxalate, calcium
and vitamin D there is a broad relationship
between urinary and dietary oxalate (Fig. 7).
It is clear, however, from the spread of the
data that factors other than the dietary intake
of oxalate alone must be involved in determining
the amount of oxalate excreted in the urine.
Increased Intestinal Absorption of Oxalate
The relationship shown in Fig. 7 is greatly
improved after account is taken of the effects
of variation in dietary calcium and in the
absorption of calcium on the amount of oxalate
available for absorption in the intestine.
Fig.
8 shows a plot of urinary oxalate against a
measure of the "free oxalate" available for
absorption in the colon.
"Free oxalate" was
calculated
by subtracting
from the dietary
intake of oxalate the amount of oxalate bound to
the non-absorbed calcium which reaches the large
bowel after
the majority of the calcium
absorption has taken pl ace in the small
intestine.
For an individual who is in calcium
balance, the amount of non-absorbed calcium is
approximately the difference between the dietary
intake of calcium and its urinary excretion.
The full expression for "free oxalate" is given
by the expression:

"Free oxalate" = 0.5 [(I 0x-Nc.-k) +
j (Nca- Ioxl2 + 2k(Nca+ lox) + k2]
where Nc = non-absorbed portion of dietary
a
calcium and is equal to (Ic -Uc)
in mmol/day for an individu•a1 in
calcium balance
dietary intake of calcium in mmol/day
dietary intake of oxalate in mmol/day
urinary excretion of calcium in
mmol/day
k is a "constant" which is a function of
the binding between calcium and oxalate
ions and of the volume of fluid in the
intestine/day.
WhenIc and I0 are in
mmoland volume is appr~ximatefy 1 litre/
day, k has the value 5.
The equation then reduces to:
"Free oxalate" = 0.5 [(I 0x-Nc.-5) +
J(Nc.-1 0.)2 + lO(Nca+ I0x) + 25]
From Fig. 8, it is clear that once the
amount of calcium absorbed in the intestine is
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the abi 1i ty of the gut to absorb ca 1c i um are
dominant factors
in the
control
of
the
absorption and subsequent urinary excretion of
oxalate.
Indeed, it may be that it is the
stone-formers'
ability
to hyperabsorb calcium
from the diet (thereby indirectly
releasing more
oxalate for absorption
and excretion
in the
urine) that is more important for increasing the
risk of stone-formation
than the hypercalciuria
with which it is more directly
associated
(Robertson and Peacock, 1980) .
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Increased EndogenousProduction of Oxalate
The mild hyperoxaluria
observed in the
majority
of idiopathic
calcium stone-formers
does not appear to be caused by an increased
basal endogenous production of oxalate
since
their fasting urinary oxalate/creatinine
ratios
and fasting plasma oxalate concentrations
are
almost identical
to those of non-stone-formers
(Robertson,
1993).
There
remains
the
possibility,
however, that
the
non-fasting
endogenous production of oxa 1ate is increased
and that this may partly explain the increased
urinary oxalate
in some patients.
Current
evidence suggests that a small proportion of the
mild hyperoxaluria
observed in the population
may derive from an increased
ingestion
and
partial metabolism of certain amino acids [such
as glycine, tyrosine,
tryptophan, phenylalamine
and hydroxypro 1i ne ( Gers hoff and Pri en, 1960)]
or from certain
sugars
[ such as 1actose,
sucrose,
fructose,
xyl itol,
sorbital
etc
(Conyers et al., 1990)].
The data in Fig. 8,
however, suggest that, at most, the contribution
of the non-fasting
endogenous production
of
oxalate to urinary oxalate must be relatively
small in comparison to the contribution
from
available exogenous oxalate.

0
2

0

4

3

Dietary Oxalate

(mmol/day)

Fig. 7. Urinary oxalate excretion in relation
to dietary oxalate taken from various studies
(x
fasting;
o
basal diet
(Western);
• = basal diet (Middle East);
t:,.
= low Ca
diet;~
= high Ca diet;
□ =low Ox diet; ■ =
high Ox diet; * = vitamin D supplements;
~ =
low Ca diet + vitamin D;
= low Ca + low Ox
diet;
• = high Ca + higti Ox diet;
.ili = low
Ca + high Ox diet).
Data are taken from
Marshall et al (1972), Hodgkinson (1978), Husain
et al (1979); Al-Ali et al. (1981), Erickson et
al (1984), Bataille
et al. (1985), Robertson et
al (1989), Robertson (1993).
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Deficiency in Oxalate-Metabolising Gut Flora

0.3

It has been suggested that the availability
of oxa 1ate for absorption may be influenced by
the flora of the gut. Two bacteria (Oxalobacter
formi genes and Pseudomonas oxa 1it i cus),
the
former of which exists in the human intestine,
have been shown to ut i 1 i se oxa 1ate within the
physiological
pH range (Allison et al.,
1985,
1986; Dawson et al., 1988). The role of these
bacteria in limiting the availability
of oxalate
for absorption in the intestine
is unknown but
it has been suggested that a deficiency
of
Oxa1obacter formi genes in the human intestine
might
increase
the
possibility
of
hyperabsorption
of oxalate
leading
to mild
hyperoxaluria.
This hypothesis remains to be
tested.
The data in Fig. 8 suggest, however,
that this cannot be a major source of the mild
hyperoxaluria of stone-formers.

0

0.2

.!:

0
0

0.2

0.4

'Free'

0.6

Dietary

0.8

Oxalate

1

1.2

1.4

1 6

(mmol/day)

Fig. 8. Urinary oxalate excretion in relation
to "free" dietary oxalate after allowance for
the binding of oxalate to non-absorbed calcium
in the intestine.
Data are taken from the same
studies as in Fig. 7 and the key is identical to
that in Fig. 7.

taken into account and the amount of dietary
oxalate
bound to the remaining calcium is
calculated,
the relationship
between urinary
oxa 1ate and the actua 1 amount of "free oxa 1ate"
available for absorption in the large bowel is
much tighter than that shown in Fig. 7 between
urinary oxalate and the total dietary intake of
oxalate.
This strongly supports the hypothesis
that the oxalate/calcium
ratio in the diet and

Change in renal handling of oxalate
It has been suggested by some that mild
hyperoxaluria
may be partly due to either
a
decrease
in the tubular
reabsorption
or an
increase in the tubular secretion
of oxalate
(Cattell
et al., 1962; Senekjian and Weinman,
1982; Borsatti,
1991). However, renal handling
studies have been hampered by the lack of a
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reliable method for measuring plasma oxalate.
Current indications are that oxalate is freely
filtered at the glomerulus but that there is no
net reabsorption either in the proximal or
distal
tubule.
On the contrary,
under
physiological conditions, only a small amount of
oxalate appears to be reabsorbed in the proximal
tubule but this is more than offset by secretion
of oxalate into the lumen of the proximal
tubule. No further transport of oxalate appears
to take place in the distal nephron.
The
combined effect of these processes is to produce
net secretion of oxalate into the proximal
tubule.
It has been further suggested that the
proximal tubular eel ls of stone-formers might
secrete more oxalate into the tubular lumen than
the proximal tubular cells of normal subjects
but no confirmation of this hypothesis has yet
been published.
It should be noted, however,
that mild hyperoxal uri a due to hypersecret ion
can only be maintained if at least one of the
above possible causes of mild hyperoxaluria is
also present. Chronic hypersecretion of oxalate
without a consistently
increased supply of
oxalate to the kidney is not possible.

Robertson et al., 1990), calcium lactate (Ito et
al., 1992) or calcium carbonate (Robertson et
al., 1992). In the latter two studies potassium
citrate was given in addition to the calcium
supplements. The concept behind this approach
is to bind oxalate in the intestine and thereby
reduce both its absorption in the colon and
subsequent appearance in urine.
In support of
this hypothesis, most of the above studies have
shown that mild hyperoxaluria can be normalised
by supplementation of the diet with calcium.
Where the calcium was given in an alkaline form
or with alkali supplements, urinary calcium
actually fell (Ito et al., 1992; Robertson et
al., 1992).
In one of our own studies from
Saudi Arabia, where both the circulating levels
of the active metabolites
of vitamin D
(Woodhouseand Norton, 1982) and the intestinal
absorption of calcium (Walker et al., 1989) are
(paradoxically) low, the increase in urinary
calcium
in
stone-formers
following
the
administration
of calcium supplements was
minimal and more than offset by the marked
decrease in urinary oxalate ( Robertson et al . ,
1990).
This form of treatment may even be of value
in the West, where the proportion of stoneformers who are hyperabsorbers of calcium is
much higher than in the Middle East, because the
fall in urinary oxalate and in the urinary
oxalate/calcium ratio should more than offset
the anticipated increase in urinary calcium.
Any increase in urinary calcium in these
i ndi vi duals
may be
further
offset
by
administering alkaline potassium citrate along
with the calcium supplements.
By stimulating
citrate production in the distal tubule, this
combined therapy would provide sufficient
citrate in the urine to complex the additional
calcium and prevent the concentration of ionized
calcium from increasing.
The net result of
these changes should be to decrease the
supersaturation of urine with respect to calcium
oxalate.
The total volume and degree of
agglomeration of calcium oxalate crystals should
also be reduced as predicted from Figs. 1-3.

Treatment of Calcium Oxalate Urolithiasis
The data in Figs. 1 to 8 have considerable
implications
for the treatment of ca lei um
oxalate stone disease.
Firstly, they strongly
indicate that treatments which rely solely on
lowering urinary calcium, either by reducing the
dietary
intake of calcium itself
or by
increasing the intake of some calcium-binding
nutrient, such as fibre, are unlikely to produce
any benefit to the patient since urinary oxalate
is bound to increase under these circumstances.
Indeed, the patient may end up in a situation
which is likely to aggravate, rather than
reduce, the risk of calcium oxalate stones.
Figs. 1, 2 and 3 show that the combination of
lowering urinary calcium and increasing urinary
oxalate will lead (i) either to no change or to
an increase in the supersaturation of urine with
respect to ca lei um oxalate, (ii) to an increase
in calcium oxalate crystalluria
and (iii) to
larger aggregates of ca lei um oxalate crystals.
All of these changes would predictably increase,
rather than decrease, the risk of calcium
oxalate stones. Unless the increase in urinary
oxalate, caused by the reduction in non-absorbed
calcium available in the intestine,
can be
prevented by simultaneously reducing the dietary
intake of oxalate,
there can be little
beneficial effect in reducing urinary calcium by
itself.
Indeed, a recent review of treatments
for calcium stone disease which are based on
reducing urinary calcium, shows that the longterm efficacy
of this
approach to stone
prevention is minimal (Marickar and Rose, 1985).
Recently, a number of workers have turned
their attention to a diametrically
opposite
approach to the prevention of calcium oxalate
stones.
Instead of reducing the amount of
calcium in the intestine,
these authors have
added supplements of calcium to the diet in the
form of calcium citrate (Harvey et al., 1985;

Conclusions
Although hypercalciuria is still considered
by many to be the main cause of calcium stone
disease, this review shows that there is little
or no relationship between any of the generally
accepted parameters of- stone-formation and the
urinary excretion of calcium.
There are,
however, strong relationships between these same
parameters and the urinary excretion of oxalate.
It
is
concluded that
persistent
mild
hyperoxal uri a is much more important than
hypercalciuria and other suggested risk factors
for increasing the risk of calcium oxalate
urolithiasis in the population.
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Discussion with Reviewers
Y. Nakagawa: What type and amount of crystal
growth i nhi bi tors are present in the urine of
the Middle Eastern stone-formers?
Authors:
So far,
we have measured the
excretions
of
various
glycosaminoglycans,
ribonucleic acid and nephrocalcin in the urines
of Saudi stone- formers, Saudi normal controls
and Western expatriate normal controls living in
Riyadh and found no significant
differences
between the groups with respect to any of these
macromolecular inhibitors.
Nor was there any
difference in the ~-carboxyglutamic acid content
of the nephrocalcin extracted from the urines of
Saudi stone-formers, Saudi normals and a sample
of normal nephrocalcin kindly supplied by Dr.
Nakagawafor comparison.
M. Menon: How is "hypercalciuria" defined in
the populations from the United Arab Emirates
and Saudi Arabia?
Is it in relation to the
excretion of calcium in normal controls in
Arabia or to that of normal contra ls in the
West?
Authors: Basically we do not use either group
of controls for defining "hypercalciuria", which
is a term that we tend to use very loosely to
refer to urines with a calcium content which
lies in the upper section of a continuous scale
of calcium excretion extending from the lowest
to highest values recorded for this urinary
constituent.
The scale may be considered,
therefore, as universal and independent of the
environment in which urinary
calcium is
determined. We envisage it as encompassing the
entire urinary range over which a "chemical
curve" may be described of the effect
of
increasing calcium concentration alone on the
risk of crystalluria
and stone-formation.
The
term "hypercalciuria" is then used to refer to
urines in the upper part of this range (>7.5
mmol/day) over which the "chemical risk curve"
begins to rise more sharply. Our usage of the
term has no physiological
or metabolic
significance or implications.
In relation to
the data from the Middle East, all we are saying
is that urinary calcium is rarely high enough~
itself to be a major chemical cause of the high
stone-formation
rate
observed
in
that
population. On the contrary, it is generally so
low that it probably prevents more people in the
population from forming stones than otherwise
would be the case if urinary calcium excretion
were higher than it is.
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M. Menon: Is the relationship shown in Fig 8
between urinary oxalate and "free" dietary
oxalate more pronounced in stone-formers than in
normals?
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W.G. Robertson and H. Hughes
Authors:
No, the derived data in Fig 8 are
calculated from studies involving both stoneformers and normals and, although no distinction
is shown in this paper between the data from
stone-formers and normals, there is, in fact, no
difference
between the fraction
of "free"
oxa1ate absorbed by the two groups at a given
level of "free" oxalate in the intestine.
If,
however, urinary oxalate is plotted against
total dietary oxalate intake from the same
studies, then the stone-formers do lie on a line
with is slightly steeper than that of the normal
subjects. This apparently greater absorption of
oxalate by the stone-formers from a given intake
of oxa1ate, however, is not due to an inherent
ability of the patients to absorb a greater
fraction of oxalate from the gut, but rather it
is a consequence of their ability to hyperabsorb
calcium. By absorbing a greater proportion of
calcium from the diet, relatively more "free"
oxalate is left in the intestine for passive
absorption lower down the gastrointestinal
tract.
Once this is taken into account, the
data of the calcium-hyperabsorbing patients come
together with those of the normals into the
relatively tight fit shown in Fig 8 since both
groups absorb the same proportion of avail ab1e
"free" oxalate probably by a passive transport
mechanism. Overall, then, the amount of oxalate
absorbed from the intestine (and excreted in the
urine) is basically a function of (a) the intake
of oxalate, (b) the intake of calcium and (c)
the ability of the gut to absorb calcium. This
is the essence of the equation defined in the
paper for the calculation of "free" oxalate.

Authors:
This is now a very contentious
question.
If our hypothesis is correct that
hypercalciuria,
by itself
is a relatively
unimportant risk factor for stone-formation,
then to lower urinary calcium alone may not be
very beneficial to the patient.
The only
exception to this situation would be if urinary
calei um can be reduced to 1ess than 4 mmo
l /day
without an accompanying increase in urinary
oxalate (see Fig. l}.
This is difficult
to
achieve in practice.
Indeed, serious doubts are
now being cast on the long-term benefits of many
urinary calcium-reducing therapies unless they
are known to have some other beneficial effect
on urinary composition, such as increasing
citrate or pyrophosphate excretion.
The question as to what level of urinary
calcium we would define as "hypercalciuria" is
difficult.
As mentioned in the answer to the
question from Dr. Menon, we tend to use the term
in a chemical rather than a biological sense.
S.H. Khan: Would the administration of calcium
citrate to stone patients increase their urinary
citrate
and thereby reduce the relative
supersaturation of urine with respect to calcium
oxalate?
Authors: Although we had hoped that this would
be the case, there is insufficient
absorbable
alkali in calcium citrate to stimulate citrate
production in the renal tubules.
Since,
moreover, virtually all the administered citrate
is metabolized, this form of treatment produces
no increase at all in either urinary pH or
citrate
excretion.
The detailed effect of
calcium
citrate
supplements on
urinary
composition is the subject of a further paper
which is in preparation.

A. Hesse: Over what range would you define "mild
hyperoxaluria"?
Authors: As in the case of "hypercalciuria", we
tend to use the term "hyperoxa1uri a" to mean a
urinary excretion of oxalate which is high
enough to increase markedly the chemical risk of
crystalluria
and stone-formation.
In practice,
"mild hyperoxaluria" commences at around 0.45
mmol/day with an "upper limit" of approximately
0.85 mmol/day. Above that figure, one would
suspect that there was a metabolic reason for
the hyperoxaluria although, as shown in Fig. 6,
the tota 1 range of urinary oxalate excretion
appears to constitute a "chemical" continuum
over which the risk of stone-formation goes on
increasing irrespective of the cause of the
hyperoxaluria.
A. Hesse: What proportion of calcium oxalate
stones in Saudi Arabia consisted of whewellite
and weddelite?
Authors: Of the predominantly calcium oxalate
stones,
72% consisted
of calcium oxalate
monohydrate and 28% were of calcium oxalate
di hydrate.
The latter often contained a small
proportion of apatite (<20%) but the whewellite
stones were usually "pure".
A. Hesse:
In your opinion, should hypercalciuria be treated any longer and what limit
would you use to define it?
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